NCT06115356

Brief Summary

Since obesity is related to systemic chronic inflammatory status and hypovitaminosis D, the study aimed to assess the incidence of hypovitaminosis D in obese patients and the correlations between vitamin D levels, inflammation indices, and bioimpedance measures. A retrospective study was conducted on a cohort of obese patients. The inflammation-based prognostic scores, diagnosis of liver fibrosis, systemic inflammatory indices, and bioimpedance measures were analyzed. The linear relationship between vitamin D levels and continuous variables was assessed through the Spearman correlation coefficient, and to determine significant predictors of vitamin D levels a stepwise multiple linear regression was used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
208

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

October 29, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 3, 2023

Completed
Last Updated

November 7, 2023

Status Verified

November 1, 2023

Enrollment Period

3.5 years

First QC Date

October 29, 2023

Last Update Submit

November 3, 2023

Conditions

Keywords

Hypovitaminosis DObesityBariatric surgeryInflammation

Outcome Measures

Primary Outcomes (1)

  • Vitamine D plasma level in patients with obesity

    To assess the incidence of hypovitaminosis D in a cohort of patients with obesity

    enrollment time

Secondary Outcomes (3)

  • Vitamin D plasma level and systemic inflammation

    enrollment time

  • Vitamin D plasma level and liver fibrosis/inflammation

    enrollment time

  • Vitamine D plasma level and bioimpedance parameters

    enrollment time

Interventions

Vitamin D Plasma LevelDIAGNOSTIC_TEST

Blood test measured in ng/ml

Measurements of body composition were conducted with Bioelectrical Impedance Analysis (BIA) technique, asking the participants to stand on the device barefoot to complete the analysis. Among all parameters, BMI, phase angle (PhA), total body water (TBW), extracellular (ECW) and intracellular water (ICW), body fat index, and fat and muscular mass were recorded.

FerritinDIAGNOSTIC_TEST

Ferritin plasma levels were measured in μg/L

CRP plasma levels were measured in mg/L

Glasgow Prognostic Score/modified Glasgow Prognostic Score (GPS/mGPS), Prognostic Nutritional Index (PNI), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte ratio (PLR), Lymphocyte-to-monocyte ratio (LMR), Systemic immune-inflammation index (SII) were calculated using blood test results

A liver biopsy was used to study nonalcoholic steatohepatitis (NASH) and fibrosis according to the Kleiner-Brunt classification

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with obesity eligible for bariatric surgery

You may qualify if:

  • BMI\> 35 Eligible for bariatric surgery according to the current international guidelines (IFSO guidelines)

You may not qualify if:

  • Patients affected by active liver viral infection
  • Patient alcohol or drug addicted
  • Incompetent patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Silvia Palmisano

Trieste, 34100, Italy

Location

Biospecimen

Retention: SAMPLES WITH DNA

Liver biopsies were studied to analyze fibrosis and inflammation grade

MeSH Terms

Conditions

Vitamin D DeficiencyObesityInflammation

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic DiseasesOverweightOvernutritionBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Silvia Palmisano, MD

    University of Trieste

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

October 29, 2023

First Posted

November 3, 2023

Study Start

January 1, 2018

Primary Completion

June 30, 2021

Study Completion

June 30, 2021

Last Updated

November 7, 2023

Record last verified: 2023-11

Locations